[The following information applies to the questions displayed below.] The December 31, 2024, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the companys year-end reporting date. Account Title Debits Credits Cash $ 75,370 Accounts receivable 21,500 Prepaid rent 2,400 Inventory 32,500 Equipment 58,000 Accumulated depreciation $ 17,400 Accounts payable 22,000 Salaries payable 0 Common stock 100,000 Retained earnings 13,000 Sales revenue 353,000 Cost of goods sold 211,800 Salaries expense 70,600 Rent expense 14,400 Depreciation expense 0 Utilities expense 14,120 Advertising expense 4,710 Totals $ 505,400 $ 505,400 The following year-end adjusting entries are required: Depreciation e